Originally published by our sister publication Infectious Disease Special Edition
By Marie Rosenthal, MS
A novel intranasal, live-attenuated COVID-19 vaccine candidate appears to induce both humoral and cellular immunity in healthy, previously unvaccinated adults, according to data being presented at IDWeek 2023, being held in Boston, Oct. 11-15 (abstract 1938).
“The data we will be presenting on Friday summarizes the immune response that we have observed in our first in-human clinical trial